![]() When available, Bid and Ask information from the Cboe BZX Exchange is updated as new data is received. The Summary Quoteboard displays snapshot quote data. If you require comprehensive real-time bids/asks/quotes, we offer a no-risk trial to one of our real-time products. As a result, the real-time prices displayed may have minor discrepancies when comparing the information with other sites offering real-time data, or with brokerage firms. Note: The Cboe BZX Exchange currently accounts for approximately 11-12% of all U.S. Real-time prices are available during market hours (9:30 AM to 4:00 PM EST). If the symbol has pre-market or post-market trades, that information will also be reflected along with the last (closing) price from the symbol's exchange. Volume always reflects consolidated markets. During market hours, the real-time Cboe BZX price displays and new trade updates are updated on the page (as indicated by a "flash"). Real-time prices are provided by Cboe BZX Exchange on individual U.S. To read this article on click here.The Quote Overview page gives you a snapshot view for a specific symbol. INFINITY PHARMA (INFI): Free Stock Analysis Report NATUS MEDICAL (BABY): Free Stock Analysis Report ![]() Click to get this free reportĪCCURAY INC (ARAY): Free Stock Analysis ReportĪBIOMED INC (ABMD): Free Stock Analysis Report Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. ![]() All the stocks sport a Zacks Rank #1 (Strong Buy). Management expects full year 2016 adjusted EPS in the band of $1.84–$1.88, while revenues are projected in the band of $445–$455 million.Ĭurrently, Natus Medical carries a Zacks Rank #3 (Hold).īetter-ranked stocks in the medical sector are Infinity Pharmaceuticals INFI, Abiomed ABMD and Accuray ARAY. For the first quarter of 2016, the company expects revenues in the range of $96.5–$97.5 million and adjusted EPS of 34–35 cents. Natus Medical reiterated the revenue and earnings guidance, provided on Jan 11. Revenues generated from Natus Medical’s service business initiatives, Peloton, GND and NicView were impressive.Īdjusted gross margin expanded 150 basis points (bps) on a year-over-year basis to 63.9%.Īdjusted operating margin expanded 130 bps on a year-over-year basis to 20.3%, on the back of higher revenues and an improving gross margin. continue to be sluggish due to unfavorable foreign exchange rate and economic uncertainties. The growth in revenues has been primarily achieved through entry into new markets and successful integration of previously completed acquisitions.ĭomestic Newborn Care and Neurodiagnostic businesses were particularly impressive, thanks to the efficiency of Natus Medical’s domestic sales organizations. Revenues from the neurology market increased 2.1% to $63 million, whereas revenues from the newborn care market improved 14.6% to $37 million. The upside may be attributed to improved performance in neurology and newborn care markets. Revenues increased 6.3% year over year to almost $100 million and were in line with the Zacks Consensus Estimate. Adjusted EPS surged 27.5% on a year-over-year basis and also surpassed the Zacks Consensus Estimate by a nickel. ![]() BABY reported adjusted earnings per share (EPS) of 51 cents in the fourth quarter of 2015. Provider of newborn care and neurology healthcare products, Natus Medical Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |